MoneyWorks4Me

The company witnessed a 20.22% growth in the revenue at Rs. 1711.37 millions for the quarter ended June 2024 as compared to Rs. 1423.51 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 137.17  millions from Rs. 168.60 millions ,decline by -18.64%.Operating Profit saw a handsome growth to 281.96 millions from 264.63 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1711.37 1423.51 20.22 1711.37 1423.51 20.22 6875.83 6167.34 11.49
Other Income 18.97 11.02 72.14 18.97 11.02 72.14 137.86 43.20 219.12
PBIDT 281.96 264.63 6.55 281.96 264.63 6.55 1214.53 1269.82 -4.35
Interest 43.73 5.09 759.14 43.73 5.09 759.14 58.94 24.14 144.16
PBDT 238.23 259.54 -8.21 238.23 259.54 -8.21 838.05 1245.68 -32.72
Depreciation 56.21 34.25 64.12 56.21 34.25 64.12 146.94 123.42 19.06
PBT 182.02 225.29 -19.21 182.02 225.29 -19.21 691.11 1122.26 -38.42
TAX 44.85 56.69 -20.89 44.85 56.69 -20.89 254.25 288.82 -11.97
Deferred Tax 8.67 3.31 161.93 8.67 3.31 161.93 45.12 25.05 80.12
PAT 137.17 168.60 -18.64 137.17 168.60 -18.64 436.86 833.44 -47.58
Equity 409.06 364.37 12.27 409.06 364.37 12.27 368.81 364.37 1.22
PBIDTM(%) 16.48 18.59 -11.37 16.48 18.59 -11.37 17.66 20.59 -14.21
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..